tric secretion, polygodial and the reference compounds, omeprazole and capsaicin, were administered orally 1 h prior to the application of ethanol, 0.6 M HCl, aspirin, and indomethacin and the pyloric ligation.
Ethanol-Induced Gastric Mucosal Lesions in Rats
The acute gastric lesions were induced by oral administration of ethanol, as previously reported. 18, 23) Briefly, 99.5% ethanol was administered to rats using a metal orogastric tube. One hour later, the animals were killed by cervical dislocation under ether anesthesia, the stomach was removed and inflated by injection of 10 ml 1.5% formalin to fix the inner and outer layers of the gastric walls. The stomach was then incised along the greater curvature and the lengths of gastric lesions were measured as previously described.
HCl-Induced Gastric Lesions in Rats
The acute gastric mucosal lesions in rats were induced by oral administration of 0.6 M HCl according to the method described by Robert et al. 24) with slight modifications. Briefly, 0.6 M HCl was administered orally at a dose of 1.5 ml/rat. One hour later, the animals were killed by cervical dislocation under ether anesthesia, the stomach was removed and inflated by injection of 10 ml 1.5% formalin to fix the inner and outer layers of the gastric walls. The stomach was then incised along the greater curvature and the lengths of gastric lesions were measured.
Aspirin-Induced Gastric Lesions in Rats
The acute gastric mucosal lesions were induced by oral administration of aspirin according to the method described by Okabe et al. 25) with slight modifications. Briefly, aspirin at a dose of 150 mg/kg suspended in 5% acacia solution (1.5 ml/rat) was administered orally. Four hours later, the rats were killed by cervical dislocation under ether anesthesia, the stomach was removed and inflated by injection of 10 ml 1.5% formalin to fix the inner and outer layers of the gastric walls. The stomach was then incised along the greater curvature and the lengths of gastric lesions were measured.
Indomethacin-Induced Gastric Lesions in Rats
The acute gastric mucosal lesion in rats by indomethacin was induced by the methods described by Wallace et al. 26) and Morise et al. 27) with slight modifications. Briefly, indomethacin (20 mg/kg, dissolved in 5% sodium bicarbonate, and then diluted in water and neutralized with 0.2 M HCl) was administered orally to rats (1.5 ml/rat). Four hours later, the animals were killed by cervical dislocation under ether anesthesia, the stomach was removed and inflated by injection of 10 ml 1.5% formalin to fix the inner and outer layers of the gastric walls. The stomach was then incised along the greater curvature and the lengths of gastric lesions were measured.
Gastric Secretion in Pylorus-Ligated Rats The effect of polygodial on the gastric acid secretion was examined using pylorus-ligated rats. Pyloric ligation was carried out according to the methods of Shay et al. 28) Rats weighing about 240 g were anesthetized with ether, then the abdomen was incised and the pylorus was ligated. Four hours later, the rats were killed and the cardia was ligated. The stomach was then removed and the gastric contents were collected in a graduated centrifuge tube. After centrifugation, the volume and pH of the gastric juice were measured. Total acidity was determined by titration with 0.1 M NaOH and acid output (mEq/h) was calculated.
Ethanol-Induced Gastric Lesions in Indomethacin-, L-NAME-, NEM-, and Ruthenium Red-Pretreated Rats Gastric mucosal lesions were induced and the lengths of gastric lesions were measured as described above. To investigate the involvement of endogenous PGs and SHs in the protective effect of polygodial, indomethacin (a PGs synthesis inhibitor) (10 mg/kg, dissolved in 5% NaHCO 3 , and diluted in water, s.c.), and NEM (an SH-blocker) (10 mg/kg, dissolved in saline, s.c.) were injected 30 min before administration of the polygodial. 29) To investigate the possible involvement of endogenous NO in the protective effect of polygodial, L-NAME (an inhibitor of NOS) (70 mg/kg, dissolved in saline, i.p.) was administered either alone or in combination with L-arginine (a substrate for NOS) (300 mg/kg, dissolved in saline, i.v.) or Darginine (300 mg/kg, dissolved in saline, i.v.) which is not a substrate for this enzyme. Injection of L-NAME was performed 30 min before administration of polygodial. L-Arginine or D-arginine was intravenously injected 10 min before L-NAME, and the effect of polygodial in L-NAME-pretreated rats was examined. 30) To investigate the possible involvement of vanilloid receptor in the protective effect of polygodial, ruthenium red (3.5 mg/kg, dissolved in saline, s.c.), which was reported to be an antagonist against capsaicin, [31] [32] [33] was injected 30 min before the administration of polygodial. The dose of ruthenium red was selected from pre-examination of this substance (2.5-7.5 mg/kg, s.c.), and its pretreatment at 5 and 7.5 mg/kg reduced spontaneous behaviors of the animals. In the ruthenium red (3.5 mg/kg)-pretreated rats, the effects of capsaicin at 2.5, 5, and 10 mg/kg were significantly reduced by 49, 30, and 21%, respectively, without affecting the behaviors.
Assay of GSH in Gastric Mucosa and Whole Stomach The amount of GSH (a non-protein SHs) in the gastric mucosa and whole stomach was measured according to the methods described by Sedlak and Lindsay 34) and Takeuchi et al. 35) with slight modifications. Briefly, polygodial or vehicle was administered to rats 1 h before administration of water or ethanol in each group. The rats were killed 1 h later. For the assay of GSH in the gastric mucosa, the stomachs were incised along the greater curvature and washed gently with cold saline. The mucosal surface of the stomach was collected by scraping, weighed and homogenized in 2 ml of 50 mM Tris-HCl buffer containing 20 mM EDTA and 0.2 M sucrose (pH 7.5). The homogenate was centrifuged at 4000 rpm for 30 min at 4°C, and 0.5 ml of 25% trichloroacetic acid was added to 1 ml of supernatant in each sample, and kept for 30 min at 4°C. After centrifugation at 4200 rpm for 40 min at 4°C, the supernatant was used to determine GSH using DTNB. Absorbance was measured at 412 nm using a spectrophotometer (Beckmann DU 530). For the assay of GSH in the whole stomach, the stomachs were removed, incised along the greater curvature and washed gently with cold saline. The stomachs were weighed and homogenized in 5 ml of buffer as described above. The homogenate was centrifuged and treated with trichloroacetic acid, and the amount of GSH in the supernatant from the whole stomach was determined as described above. Results of the GSH level in the gastric mucosa and the whole stomach were expressed as micromoles per gram wet tissue weight (mmol/g wet weight).
Statistics Values were expressed as meansϮS.E.M. For statistical analysis, one-way analysis of variance followed by Dunnett's test was used. Probability (p) values less than 0.05 were considered significant. ED 50 values with 95% confidence limits (95% C.L.) were estimated based on linear regressions of probit-transformed values of inhibition (%).
RESULTS

Effect of Polygodial on Gastric Lesions Induced by
Necrotizing Agents in Rats Polygodial (0.025-0.5 mg/kg, p.o.) significantly reduced the mucosal lesions in a dose-dependent manner (ED 50 ϭ0.029 mg/kg, p.o.), and its effect was stronger than those of capsaicin and omeprazole (Table 1) . Oral administration of 0.6 M HCl, aspirin (150 mg/kg), or indomethacin (20 mg/kg) at a volume of 1.5 ml/rat produced gastric mucosal lesions in rats. Polygodial (0.2-1.0 mg/kg, p.o.) dose-dependently inhibited the formation of gastric lesions induced by these necrotizing agents (Tables  2-4 Aspirin (150 mg/kg, 1.5 ml/rat) was orally administered to 24-h fasted rats. Four hours later, rats were killed and the total length (mm) of gastric lesions was determined. Test samples were administered orally 1 h before administration of aspirin. Values represent the meansϮS.E.M. Significantly different from the control group, * pϽ0.05, ** pϽ0.01. Effect on Gastric Lesions Induced by Ethanol in Indomethacin-Pretreated Rats As shown in Table 6 , pretreatment with indomethacin (10 mg/kg, s.c.) significantly reduced the protective effect of polygodial at all doses tested, especially at doses of 0.05 and 0.1 mg/kg; this inhibition was reduced 3-fold (from 61.5 to 18.5%) and about 2-fold (from 80.2 to 35.7%), respectively.
Effect on Gastric Lesions in L-NAME-, and Combination of L-NAME with L-Arginine-or D-Arginine-Pretreated Rats Pretreatment with L-NAME (70 mg/kg, i.p.) significantly aggravated ethanol-induced mucosal lesions and reduced the protective effect of polygodial at all doses tested, especially at doses of 0.05 and 0.1 mg/kg, where inhibitions were reduced from 59.4 to 31.2% and from 77.2 to 46.0%, respectively. The combination of L-arginine (300 mg/kg, i.v.) with L-NAME reversed the protective activity of polygodial, whereas in combination with D-arginine (300 mg/kg, i.v.) under the same conditions, the aggravation of the gastric lesions remained (Table 7) . Table 8) .
Effect on Gastric Lesions Induced by Ethanol in NEMPretreated Rats and on GSH Contents in the Gastric
The effects of polygodial on the amount of GSH in the gastric mucosa and whole stomach are shown in Table 9 . In comparison to the normal group (vehicleϩwater), the mucosal GSH level in the ethanol-treated group was decreased about 34% (from 5.48 to 3.59 mmol/g wet weight), although the difference was not significant. In both water and ethanoltreated groups, polygodial tended to increase the level of GSH in both the gastric mucosa and whole stomach, and this increase was significant at a dose of 0.2 mg/kg: about 53% (from 0.71 to 1.09 mmol/g wet weight) in the whole stomach of the water-treated group and about 63% (from 3.59 to 5.86 654 Vol. 26, No. 5 The pylorus was ligated under light ether anesthesia. Four hours later, the animals were killed and the gastric juice was collected and centrifuged. The volume and pH of the juice were measured. Acid output was determined by titration with 0.1 M NaOH, and the results are expressed as mEq/h. Values represent the meansϮS.E.M. Significantly different from the control group, * pϽ0.05, ** pϽ0.01. 72.0 L-NAME (70 mg/kg, i.p.) was injected 30 min before administration of the polygodial or vehicle. L-Arginine (300 mg/kg, i.v.) or D-arginine (300 mg/kg, i.v.) was injected 10 min before the administration of L-NAME. Polygodial was orally administered 1 h before administration of ethanol. Values represent the meansϮS.E.M. Significantly different from each control group, ** pϽ0.01, from the corresponding group in normal rats, † pϽ0.05, † † pϽ0.01, and from the corresponding group in L-NAME-pretreated rats, # pϽ0.05. mmol/g wet weight) in gastric mucosa of ethanol-treated group.
Effect on Gastric Lesions Induced by Ethanol in Ruthenium Red-Pretreated Rats Pretreatment with ruthenium red (3.5 mg/kg, s.c.) significantly reduced the gastroprotective effect of polygodial at doses of 0.05 and 0.1 mg/kg (p.o.), but not at 0.2 mg/kg (Table 10) .
DISCUSSION
The necrotizing agents ethanol, 0.6 M HCl, aspirin and indomethacin produce gastric mucosal damage in rats. Polygodial (0.025-1.0 mg/kg, p.o.) significantly inhibited the formation of gastric lesions induced by these agents, especially by ethanol. However, for the indomethacin-treated group, polygodial showed significant inhibition, although not dosedependently at doses above 0.2 mg/kg.
A reference compound, omeprazole, inhibited the gastric mucosal damage produced by these necrotizing agents. In agreement with previous reports, 36) capsaicin inhibited gastric lesions induced by ethanol, aspirin, and indomethacin. However, in the present study, capsaicin (0.01-50 mg/kg, p.o.) did not have any effect on 0.6 M HCl-induced gastric lesions, although at low concentration it was reported to inhibit 0.6 M HCl-induced gastric lesions in rats. 37) These results suggested that the mode of action of polygodial is different from capsaicin in indomethacin and 0.6 M HCl-induced gastric lesions.
Polygodial and capsaicin did not show a significant change in acid output at their effective doses against ethanol-induced gastric lesions, suggesting that their gastroprotective effects are acid-independent, differing from omeprazole.
PGs have been shown to have a wide spectrum of gastroprotective activity. 38) Chaudhury and Robert reported that mild irritants protected the gastric mucosal damage by releasing endogenous PGs. 39) Pretreatment with indomethacin, a PGs biosynthesis inhibitor, markedly attenuated the gastroprotective effect of polygodial on ethanol-induced gastric lesions. This result suggests that PGs are involved in the gastroprotection by polygodial.
NO is known as a potent vasorelaxing factor secreted from endothelial cells or the sensory nerve ending in the mucosa. 40) NO participated in the gastric defense mechanism by regulating the gastric mucosal blood flow, gastric mucus secretion, and increase in PGs biosynthesis. [41] [42] [43] It was reported that the gastric mucosa forms endogenous NO derived from L-arginine, and the NO production is blocked by analogues of L-arginine such as L-NAME. 44, 45) In the present study, treatment with L-NAME markedly attenuated the protective effect of polygodial, which was reversed by addition of L-arginine but not D-arginine. These findings suggest that NO is involved in the protective effect of polygodial. Oxygen-derived free radicals and lipid peroxidation are associated with gastrointestinal lesions, and antioxidants prevent the lesions by various ulcerogens. Gastric mucosal SHs including GSH act as antioxidant, and are important for maintenance of mucosal integrity in the stomach. 46, 47) Ethanol-induced gastric damage is also associated with a significant decrease in mucosal SHs level such as GSH, and pretreatment with SH-blockers prevents the gastroprotection of SH-containing compounds. 48, 49) In agreement with previous findings, the concentration of GSH in the gastric mucosa tended to decrease after administration of ethanol, and polygodial inhibited the decrease in GSH levels. In addition, pretreatment with an SH-blocker, NEM, markedly reduced the mucosal protection afforded by polygodial at all doses tested, especially at a dose of 0.05 mg/kg. These findings suggest that an increase in endogenous SHs is involved in the protective effect of polygodial.
Recently, various sesquiterpene dialdehydes and related terpenoids including polygodial were reported to be able to act as VR1 agonists, and these compounds stimulate capsaicin-sensitive neurons in a vanilloid receptor-mediated fashion, although they are structurally unrelated to either capsaicin or resiniferatoxin. 7, 50) Capsaicin sensory nerves play an important role in gastric defense mechanisms, which counteract the effects of ulcerogens. Vanilloid receptors on the gastrointestinal mucosa are involved in gastroenteric motility regulation, acid secretion, increases in gastric blood flow through the action of calcitonin gene-related peptide (CGRP), stimulation of bicarbonate and gastric mucus secretion or maintenance of mucosal integrity in the presence of noxious substances. The vasodilator action of CGRP in the rat stomach was reported to involve the formation of NO, at least in part. The cyclooxygenase inhibitor, indomethacin, has been reported to diminish the capsaicin-induced increase in gastric mucosal blood flow, although capsaicin failed to alter the ex vivo formation of PGE 2 , 6-oxo-prostaglandin F 1a , and leukotriene C 4 in the rat gastric mucosa. 19, 31, 51) Ruthenium red is reported to be a functional capsaicin antagonist. 32, 33, 52) In the present study, pretreatment with ruthenium red (3.5 mg/kg, s.c.) reduced the protection afforded by polygodial (0.05 and 0.1 mg/kg, p.o.). Similar to VR1 agonists, endogenous NO and PGs are involved in the protective effect of polygodial as described above, although the mode of action of polygodial was different from capsaicin in indomethacin and 0.6 M HCl-induced gastric lesions. These findings and those of previous studies suggest that the gastroprotective action of polygodial is partly mediated by interactions with capsaicin-sensitive sensory neurons via VR1.
In conclusion, polygodial markedly inhibited the gastric mucosal lesions induced by ethanol, 0.6 M HCl and aspirin and partly inhibited indomethacin-induced gastric lesions, but it did not show a significant effect on acid output in pylorus-ligated rats at doses of 0.05-0.5 mg/kg. With regard to the mechanism of action, endogenous PGs, NO, SHs, and vanilloid receptor-mediated effects are involved in the protective effect of polygodial.
